Recall Radar
All recallsMedicine & devices

Semaglutide, For Rx compounding use only, packaged in a) 1g, NDC 84385-106-01; b) 5g, NDC 84385-106-02; c) 10g, NDC 84385-106-06; d) 25g, NDC 84385-106-03; d) 50g, NDC 84385-106-0…

CGMP Deviations This recall has been initiated due to failing to complete process validation and bacterial endotoxin method validation before distribution

Class II Medicine & devices FDA March 11, 2026 Reached Texas
Read the official FDA notice →

What to do

Stop using the product and check it against the description above. Follow the remedy on the official notice; most recalls are refunded or replaced without a receipt. If you or a family member has already been affected, keep the packaging and the lot code — they're what a claim rests on later.

Details

Recalling company
Harbin Jixianglong Biotech Co., Ltd. — Haerbin, N/A
Severity
Class II — moderate
Reported
March 11, 2026
Quantity
N/A
Recall number
D-0379-2026
Status
Ongoing
Source
FDA

Where it went

Nationwide within the United States

Other medicine & devices recalls

See every current recall on the live dashboard →